RAF ONCOGENE ANALYSIS AND RADIATION RESISTANT TUMOR CELL

RAF癌基因分析和抗辐射肿瘤细胞

基本信息

  • 批准号:
    3458673
  • 负责人:
  • 金额:
    $ 8.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-02-15 至 1993-01-31
  • 项目状态:
    已结题

项目摘要

The search for the cause and effect of genetic changes associated with neoplastic cells occupies a central place in cancer research. A year and a half ago, we began to address the possible causes of a human laryngeal cancer. We have now reported the association of an abnormal RAF oncogene with a radiation resistant human laryngeal carcinoma cell line, SQ-20B. Our studies have been complemented by the independent observations made in another laboratory that noncancerous, radiation resistant skin fibroblasts of patients with a familial history of radiation resistant malignancies reveal an abnormal RAF oncogene. However, these two reports have not yet proven the precise nature of this abnormality, nor its relevance to the resistance of target cells to radiation toxicity. Our major gaols during the tenure of this grant period will be to study the modulation of RAF gene expression and the cellular responses to radiation-damage as a consequence of delivering an optimal expression of sense or anti-sense RAF to the appropriate mammalian cells (AIM I), to dissect and characterize the RAF oncogene structure and function in SQ-20B cells (AIM II), and to search for genetic abnormalities in three additional closely related human cancers (AIM III). We will use a clearly defined, feasible, and integrated approach to evaluate the genetic basis of malfunctioning of the RAF in SQ- 20B cells. These studies are greatly facilitated by the availability of cloned and defined unique expression vectors containing human RAF(sense/anti-sense) sequence, c-RAF-1 DNA probes, riboprobe vector probes suitable for RAF (anti-sense+) analysis, and antibody to RAF protein from Dr. George Mark (NIH). We will maintain our ongoing collaborative efforts with Drs. Anatoly Dritschilo, George Mark, and Michael Gottesman for their specific expertise in the areas of radiobiology, molecular biology of RAF, and molecular biology of multidrug resistance, respectively. Finally, the current investigations should lead us to begin to elucidate the structure and function of RAF proto- oncogene domains pivotal to the maintenance of normal cell proliferation and behavior.
对基因变化的因果关系的研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Usha N. Kasid其他文献

Hodgkin disease: pharmacologic intervention of the CD40-NFκB pathway by a protease inhibitor
  • DOI:
    10.1182/blood.v96.8.2841
  • 发表时间:
    2000-10-15
  • 期刊:
  • 影响因子:
  • 作者:
    Christina M. Annunziata;Yassamin J. Safiran;Steven G. Irving;Usha N. Kasid;Jeffrey Cossman
  • 通讯作者:
    Jeffrey Cossman

Usha N. Kasid的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Usha N. Kasid', 18)}}的其他基金

Mechanistic significance of a novel molecular target in the FOXO signaling pathwa
FOXO 信号通路中新分子靶点的机制意义
  • 批准号:
    8748694
  • 财政年份:
    2014
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6443862
  • 财政年份:
    2001
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6300542
  • 财政年份:
    2000
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6334986
  • 财政年份:
    2000
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6217506
  • 财政年份:
    1999
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6103357
  • 财政年份:
    1999
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6269833
  • 财政年份:
    1998
  • 资助金额:
    $ 8.72万
  • 项目类别:
OLIGONUCLEOTIDE MANIPULATION OF TUMOR CELL RADIORESISTANCE
寡核苷酸调控肿瘤细胞辐射抗性
  • 批准号:
    6237797
  • 财政年份:
    1997
  • 资助金额:
    $ 8.72万
  • 项目类别:
RAF KINASE RADIATION AND CANCER CELL SIGNAL TRANSDUCTION
RAF 激酶辐射和癌细胞信号转导
  • 批准号:
    2112250
  • 财政年份:
    1995
  • 资助金额:
    $ 8.72万
  • 项目类别:
REGULATION OF RADIORESISTANCE IN HUMAN RENAL CANCER CELL
人肾癌细胞辐射抗性的调节
  • 批准号:
    3203085
  • 财政年份:
    1992
  • 资助金额:
    $ 8.72万
  • 项目类别:

相似海外基金

Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
  • 批准号:
    MR/Y002164/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.72万
  • 项目类别:
    Research Grant
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
  • 批准号:
    10638634
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
  • 批准号:
    10643423
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
  • 批准号:
    10713648
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
  • 批准号:
    10750627
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
利用可点击的抗体对逆转肿瘤的耐药性
  • 批准号:
    10566266
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
Mathematical Modeling of Drug Resistance Evolution and The Optimal Treatment Strategy in EGFR Mutated Lung Cancer
EGFR突变肺癌耐药演化的数学模型及最佳治疗策略
  • 批准号:
    22KJ0768
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Elucidation of prion strain-specific effect of antiprion drugs and drug resistance mechanisms
阐明抗朊病毒药物的朊病毒株特异性作用和耐药机制
  • 批准号:
    23H02828
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
靶向肿瘤和 TME 中的 RAGE,对抗肥胖相关 ER 乳腺癌的炎症和耐药性
  • 批准号:
    10734834
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
Exosomal microRNAs in peritoneal fluid of gastric cancer patients with peritoneal metastasis induce drug resistance
胃癌腹膜转移患者腹腔液中的外泌体microRNA诱导耐药
  • 批准号:
    23K14650
  • 财政年份:
    2023
  • 资助金额:
    $ 8.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了